Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan · Delayed Price · Currency is TWD 73.80
+3.30 (4.68%)
Oct 9, 2025, 1:30 PM CST
Taiwan Biomaterial Market Cap
Taiwan Biomaterial has a market cap or net worth of 3.10 billion as of October 10, 2025. Its market cap has increased by 138.06% in one year.
Market Cap
3.10B
Enterprise Value
2.81B
Revenue
157.98M
Ranking
n/a
PE Ratio
115.29
Stock Price
73.80
Market Cap Chart
Since August 29, 2017, Taiwan Biomaterial's market cap has increased from 2.34B to 3.10B, an increase of 32.46%. That is a compound annual growth rate of 3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 3.10B | 115.79% |
| Dec 31, 2024 | 1.44B | 9.27% |
| Dec 29, 2023 | 1.31B | -9.80% |
| Dec 30, 2022 | 1.46B | 78.08% |
| Dec 30, 2021 | 818.40M | -16.50% |
| Dec 31, 2020 | 980.10M | -22.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |